Marsh & McLennan on Pace for Largest Percent Increase Since April 2023 — Data Talk
Marsh & McLennan Companies, Inc. (MMC) is currently at $204.42, up $6.81 or 3.44%
--Would be highest close since April 5, 2024, when it closed at $205.58
--On pace for largest percent increase since April 20, 2023, when it rose 3.54%
--Currently up two consecutive days; up 4.14% over this period
--Best two day stretch since the two days ending Nov. 11, 2022, when it rose 4.58%
--Down 0.75% month-to-date
--Up 7.89% year-to-date
--Down 1.67% from its all-time closing high of $207.90 on March 13, 2024
--Up 13.76% from 52 weeks ago (April 20, 2023), when it closed at $179.70
--Down 1.67% from its 52-week closing high of $207.90 on March 13, 2024
--Up 18.13% from its 52-week closing low of $173.05 on May 24, 2023
--Traded as high as $206.50; highest intraday level since March 28, 2024, when it hit $206.74
--Up 4.49% at today's intraday high; largest intraday percent increase since Nov. 10, 2022, when it rose as much as 5.84%
--Seventh best performer in the S&P 500 today
All data as of 10:02:16 AM ET
Source: Dow Jones Market Data, FactSet
(END) Dow Jones Newswires
April 18, 2024 10:20 ET (14:20 GMT)
Copyright (c) 2024 Dow Jones & Company, Inc.-
Magnificent 7 Stocks Earnings Updates: AI Remains the Focus
-
Small-Cap and Value Stocks Are Undervalued
-
Why We Expect the Job Market’s Slowdown to Renew in 2024
-
5 Undervalued Stocks to Buy to Play a Little Defense
-
Markets Brief: AI Leaders Excel In Earnings Season So Far
-
What History Tells Us About the Fed’s Next Move
-
What’s Happening In the Markets This Week
-
Alphabet’s New Dividend: What Investors Need to Know
-
Amazon Earnings: AWS Growth Accelerates and Profit Margins Improve
-
SiriusXM Earnings: Decent Results With Plan for Technology and Content Investment to Drive Growth
-
Coca-Cola Earnings: Solid Volume On Innovation and Digital Engagement
-
Is Berkshire Hathaway a Buy Before the Annual Meeting?
-
Investment Opportunities in the Drug Distribution Industry
-
Why the End of Quantitative Tightening Matters
-
Eli Lilly Earnings: Strong Weight-Loss Drug Sales Expand Margins
-
After Earnings, Is Meta Stock a Buy, a Sell, or Fairly Valued?